PEG — Pharma Equity A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK122.75m
- DKK137.53m
Annual cashflow statement for Pharma Equity A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.9 | 5.39 | 3.48 | -26.8 | -26.2 |
| Depreciation | |||||
| Non-Cash Items | 24.1 | -6.83 | -7.75 | 5.92 | 4.96 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.15 | -0.647 | 1.4 | 3.82 | -1.82 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.9 | -2.09 | -2.87 | -16.6 | -22.9 |
| Capital Expenditures | — | — | — | -0.073 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | — | -0.073 | 0 |
| Financing Cash Flow Items | — | — | — | -3.85 | -8.21 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.9 | 2.09 | 3.06 | 17.1 | 22.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0.182 | 0.363 | 0.003 |